Synosia Therapeutics

Synosia Therapeutics is a company that focuses on developing and selling products for unmet medical needs in psychiatry and neurology. The company has six clinical-stage compounds in its pipeline that were acquired through partnerships with Novartis, Roche, and Syngenta. Two of these compounds are marketed drugs being tested in new indications to extend their reach into neurological and psychiatri...